A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT03583944 · COMPLETED
Trial details
- NCT number
- NCT03583944
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-28
- Primary completion
- 2019-06-28
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.